Content creators mean business
Social media influencers are flipping the rules by first getting followers and then launching products and ...
Australian scientists have found that an antiviral drug called ‘Ivermectin’ was able to kill coronavirus grown in cell cultures in less than 48 hours.
Ivermectin is a medication used to treat many types of parasite infestations.
This study comes as researchers and scientists are scouring drugs that can be repurposed or used to treat the novel coronavirus.
The study, published in the journal Antiviral Research, stated that Ivermectin was able to kill the virus in less than two days.
Also read: Govt steers clear of adverse vaccine event
The study further said that the anti-parasitic drug significantly reduced the viral load in 24 hours.
Ivermectin is an approved anti-parasitic drug known to be effective against a variety of viruses like HIV, influenza, dengue, and Zika.
The researchers cautioned that more testing needs to be done to be sure of the drug’s efficacy against Covid-19.
Even though the drug is considered largely safe, the scientists at the Monash University in Australia who conducgted the study, are yet to ascertain the correct dosage and effects to understand its efficacy against SARS-CoV-2.
Also read: Plant-based vaccines take baby steps in global fight against Covid-19
The researchers believe that instead of finding new ways to treat the infection, scientists should focus on tweaking the existing treatment in order to prevent the infection.
The researchers, however, did not say how Ivermectin was able to destroy Covid-19, but they believe that the drug inhibits Covid-19 replication.
Social media influencers are flipping the rules by first getting followers and then launching products and ...
Paneer, once alien to the South, has found a lucrative market in Chennai
WPP agency Wunderman Thompson has launched its annual Future 100 report, lifting the lid on trends shaping the ...
Carriers claim that all measures — including pre-flight tests, cabin sanitisation and fresh air inflow — have ...
What filters should you apply when mining for under-the-radar small-cap stocks? Read on to find more
High valuation, intensely competitive landscape and small cap nature of the stock are key risks.
Amid choppiness, the benchmark indices slipped marginally; approach the week with caution
SBI Cards (₹1,032.7): Witnesses fresh breakoutBetween September and December last year, the stock of SBI Cards ...
A virus swept aside 2020 plans to mark the 250th year of the birth of Beethoven. We need the German composer’s ...
A mysterious new exhibit has been the centre of attraction at the gallery of Modern Art. This art work has ...
Tara was a curious little girl who loved to ask questions.She lived with her parents and her grandmother — ...
On the day the oleander baby was born, there was a steady, happy drizzle. Madhu woke up feeling unsteady. The ...
Social media influencers are flipping the rules by first getting followers and then launching products and ...
WPP agency Wunderman Thompson has launched its annual Future 100 report, lifting the lid on trends shaping the ...
Paneer, once alien to the South, has found a lucrative market in Chennai
The Flipkart kids playing adults are back — this time to push the home grown e-commerce marketplace’s grocery ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor